Evidence map›Paper›PMID 28664613›Full record

ArticleJournal of cellular and molecular medicine2017

YB-1 orchestrates onset and resolution of renal inflammation via IL10 gene regulation.

Jialin Wang, Sonja Djudjaj, Lydia Gibbert, Vera Lennartz, Daniel M Breitkopf, Thomas Rauen, Daniela Hermert, Ina V Martin, Peter Boor, Gerald S Braun and 3 more

Open access · goldAbstract read
In one paragraph

Article in Journal of cellular and molecular medicine, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 15 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
15citing papers in PubMed, 1 pooled it
1.5field-weighted citation impact, top 19% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

15 citing papers in PubMed, 1 synthesis or guideline pooled it, 31 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Review
  9. Review
  10. Review
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 1 institution in 1 country.

Jialin WangDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Sonja DjudjajInstitute of Pathology, University Hospital RWTH-Aachen, Aachen, Germany.
Lydia GibbertDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Vera LennartzDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Daniel M BreitkopfDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Thomas RauenDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Daniela HermertDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Ina V MartinDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Peter BoorInstitute of Pathology, University Hospital RWTH-Aachen, Aachen, Germany.
Gerald S BraunDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Jürgen FloegeDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Tammo OstendorfDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.
Ute RaffetsederDepartment of Nephrology and Clinical Immunology, University Hospital RWTH-Aachen, Aachen, Germany.ORCID http://orcid.org/0000-0002-7236-9793
RWTH Aachen University · DE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The Y-box-binding protein (YB)-1 plays a non-redundant role in both systemic and local inflammatory response. We analysed YB-1-mediated expression of the immune regulatory cytokine IL-10 in both LPS and sterile inflammation induced by unilateral renal ischaemia-reperfusion (I/R) and found an important role of YB-1 not only in the onset but also in the resolution of inflammation in kidneys. Within a decisive cis-regulatory region of the IL10 gene locus, the fourth intron, we identified and characterized an operative YB-1 binding site via gel shift experiments and reporter assays in immune and different renal cells. In vivo, YB-1 phosphorylated at serine 102 localized to the fourth intron, which was paralleled by enhanced IL-10 mRNA expression in mice following LPS challenge and in I/R. Mice with half-maximal expression of YB-1 (Yb1

Indexed as

Gene Expression RegulationAnimalsBase SequenceBinding SitesElectrophoretic Mobility Shift AssayExonsHeterozygoteHomozygoteInflammationInterleukin-10IntronsKidneyLipopolysaccharidesMaleMiceMice, TransgenicIL10 protein, mouseInterleukin-10LipopolysaccharidesRNA, MessengerTranscription FactorsYbx1 protein, mousefourth intronIL-10ischaemia-reperfusionLPSrenal fibrosisrenal inflammationYB-1

Identifiers

PMID28664613
PMCPMC5706504
OpenAlexW2734083947

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.